Recombinant NAD-dependent SIR-2 Protein of Leishmania donovani: Immunobiochemical Characterization as a Potential Vaccine against Visceral Leishmaniasis

PLoS Neglected Tropical Diseases

Volumn 9, Issue 3, 2015, Pages

  Baharia, Rajendra K ^a   Tandon, Rati ^a   Sharma, Tanuj ^a   Suthar, Manish K ^a   Das, Sanchita ^a   Siddiqi, Mohammad Imran ^a   Saxena, Jitendra Kumar ^a   Sunder, Shyam ^b   Dube, Anuradha ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLUTARALDEHYDE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; NITRIC OXIDE; RECOMBINANT NAD DEPENDENT SILENT INFORMATION REGULATOR PROTEIN; SILENT INFORMATION REGULATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; LEISHMANIA VACCINE; NICOTINAMIDE ADENINE DINUCLEOTIDE; PROTOZOAL PROTEIN; RECOMBINANT VACCINE; SIRTUIN 2;

ADOLESCENT; ADULT; ANIMAL CELL; ARTICLE; BIOINFORMATICS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FEMALE; FLUORESCENCE MICROSCOPY; HELPER CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOLOCALIZATION; LEISHMANIA DONOVANI; MALE; MOLECULAR CLONING; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROMASTIGOTE; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REAL TIME POLYMERASE CHAIN REACTION; VISCERAL LEISHMANIASIS; WESTERN BLOTTING; ANIMAL; BIOLOGY; BIOSYNTHESIS; HAMSTER; IMMUNIZATION; IMMUNOLOGY; LEISHMANIASIS, VISCERAL; LYMPHOCYTE ACTIVATION; MESOCRICETUS; PHYSIOLOGY;

ADULT; ANIMALS; COMPUTATIONAL BIOLOGY; CRICETINAE; CYTOKINES; HUMANS; IMMUNIZATION; LEISHMANIA DONOVANI; LEISHMANIASIS VACCINES; LEISHMANIASIS, VISCERAL; LYMPHOCYTE ACTIVATION; MALE; MESOCRICETUS; NAD; NITRIC OXIDE; PROTOZOAN PROTEINS; SIRTUIN 2; VACCINES, SYNTHETIC;

EID: 84928817150     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003557     Document Type: Article

References (70)

1. Herwaldt BL, (1999) Leishmaniasis. Lancet 354: 1191–1199. 10513726
2. Guerin PJ, Olliaro P, Sundar S, Boelaert M, Croft SL, et al. (2002) Visceral Leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis 2: 494–501. 12150849
3. Singh SP, Reddy DC, Rai M, Sundar S, (2006) Serious underreporting of visceral Leishmaniasis through passive case reporting in Bihar, India. Trop Med Int Health 11: 899–905. 16772012
4. Singh VP, Ranjan A, Topno RK, Verma RB, Siddique NA, et al.(2010) Estimation of under-reporting of visceral Leishmaniasis cases in Bihar, India. Am J Trop Med Hyg 82: 9–11. doi: 10.4269/ajtmh.2010.09-0235 20064987
5. Desjeux P, (2004) Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27: 305–318. 15225981
6. Handman E, (2001) Leishmaniasis: current status of vaccine development. Clin Microbiol Rev 14: 229–243 11292637
7. Haldar JP, Ghose S, Saha KC, Ghose AC, (1983) Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal Leishmaniasis. Infect Immun 42: 702–707. 6642649
8. Karp CL, el-Safi SH, Wynn TA, Satti MM, Kordofani AM, et al. (1993) In vivo cytokine profiles in patients with kala-azar marked elevation of both interleukin-10 and interferon-gamma. J Clin Invest 91: 1644–1648. 8097208
9. Peruhype-Magalhaes V, Martins-Filho OA, Prata A, Silva Lde A, Rabello A, et al. (2005) Immune response in human visceral leishmaniasis: analysis of the correlation between innate immunity cytokine profile and disease outcome. Scand J Immunol 62: 487–495 16305646
10. Kemp M, Kurtzhals JA, Bendtzen K, Poulsen LK, Hansen MB, et al. (1993) Leishmania donovani reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis. Infect Immun 61: 1069–1073. 8432588
11. Gupta SK, Sisodia BS, Sinha S, Hajela K, Naik S, et al. (2007) Proteomic approach for identification and characterization of novel immunostimulatory proteins from soluble antigens of Leishmania donovani promastigotes. Proteomics 7: 816–823. 17295358
12. Yahiaoui B, Taibi A, Ouaissi A, (1996) A Leishmania major protein with extensive homology to silent information regulator 2 of Saccharomyces cerevisiae. Gene 169: 115–118. 8635734
13. Vergnes B, Sereno D, Madjidian-Sereno N, Lemesre JL, Ouaissi A, (2002) Cytoplasmic SIR2 homologue overexpression promotes survival of Leishmania parasites by preventing programmed cell death. Gene 296: 139–150. 12383511
14. Vergnes B, Sereno D, Tavares J, Cordeiro-da-Silva A, Vanhille L, et al. (2005) Targeted disruption of cytosolic SIR2 deacetylase discloses its essential role in Leishmania survival and proliferation. Gene 363: 85–96. 16236469
15. Garg R, Gupta SK, Tripathi P, Naik S, Sundar S, et al. (2005) Immunostimulatory cellular responses of cured Leishmania-infected patients and hamsters against the integral membrane proteins and non-membranous soluble proteins of a recent clinical isolate of Leishmania donovani. Clin Exp Immunol 140: 149–156. 15762886
16. Dube A, Singh N, Sundar S, (2005) Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models. Parasitol Res 96: 216–223. 15868188
17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ, (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275. 14907713
18. Towbin H, Staehelin T, Gordon J, (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76: 4350–4354. 388439
19. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, et al. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947–2948. 17846036
20. Goujon M, McWilliam H, Li W, Valentin F, Squizzato S, et al.(2010) A new bioinformatics analysis tools framework at EMBL-EBI. Nucleic Acids Res 38: W695–699. doi: 10.1093/nar/gkq313 20439314
21. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al.(2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28: 2731–2739. doi: 10.1093/molbev/msr121 21546353
22. Kumar S, Stecher G, Peterson D, Tamura K, (2012) MEGA-CC: computing core of molecular evolutionary genetics analysis program for automated and iterative data analysis. Bioinformatics 28: 2685–2686. doi: 10.1093/bioinformatics/bts507 22923298
23. Nei M, Tajima F, Tateno Y, (1983) Accuracy of estimated phylogenetic trees from molecular data. II. Gene frequency data. J Mol Evol 19: 153–170. 6571220
24. Bila DC, Young P, Merks H, Vubil AS, Mahomed M, et al.(2013) Evolution of primary HIV drug resistance in a subtype C dominated epidemic in Mozambique. PLoS One 8: e68213. doi: 10.1371/journal.pone.0068213 23935858
25. Lightfoot DA, Iqbal MJ, (2013) Molecular mapping and breeding with microsatellite markers. Methods Mol Biol 1006: 297–317. doi: 10.1007/978-1-62703-389-3_20 23546799
26. Sambasiva Rao KR, Srinivasa Rao D, (2012) A comparative-based phylogenetic study in the evolution of 16S rRNA and rad a genes in Archaea. Int J Data Min Bioinform 6: 396–405. 23155770
27. Frith MC, Saunders NF, Kobe B, Bailey TL, (2008) Discovering sequence motifs with arbitrary insertions and deletions. PLoS Comput Biol 4: e1000071. doi: 10.1371/journal.pcbi.1000071 18437229
28. Bailey TL, Boden M, Buske FA, Frith M, Grant CE, et al. (2009) MEME SUITE: tools for motif discovery and searching. Nucleic Acids Res 37: W202–208. doi: 10.1093/nar/gkp335 19458158
29. Geer LY, Domrachev M, Lipman DJ, Bryant SH, (2002) CDART: protein homology by domain architecture. Genome Res 12: 1619–1623. 12368255
30. Marchler-Bauer A, Lu S, Anderson JB, Chitsaz F, Derbyshire MK, et al.(2011) CDD: a Conserved Domain Database for the functional annotation of proteins. Nucleic Acids Res 39: D225–229. doi: 10.1093/nar/gkq1189 21109532
31. Schultz J, Copley RR, Doerks T, Ponting CP, Bork P, (2000) SMART: a web-based tool for the study of genetically mobile domains. Nucleic Acids Res 28: 231–234. 10592234
32. Vita R, Zarebski L, Greenbaum JA, Emami H, Hoof L, et al. (2010) The immune epitope database 2.0 Nucleic Acids Res 38: D854–862. doi: 10.1093/nar/gkp1004 19906713
33. Peters B, Sette A, (2005) Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method. BMC Bioinformatics 6: 132. 15927070
34. Kim Y, Sidney J, Pinilla C, Sette A, Peters B, (2009) Derivation of an amino acid similarity matrix for peptide: MHC binding and its application as a Bayesian prior. BMC Bioinformatics 10: 394. doi: 10.1186/1471-2105-10-394 19948066
35. Sidney J, Assarsson E, Moore C, Ngo S, Pinilla C, et al. (2008) Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries. Immunome Res 4: 2. doi: 10.1186/1745-7580-4-2 18221540
36. Moutaftsi M, Peters B, Pasquetto V, Tscharke DC, Sidney J, et al. (2006) A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus. Nat Biotechnol 24: 817–819. 16767078
37. Hoof I, Peters B, Sidney J, Pedersen LE, Sette A, et al. (2009) NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics 61: 1–13. doi: 10.1007/s00251-008-0341-z 19002680
38. Xiang Z, He Y, (2013) Genome-wide prediction of vaccine targets for human herpes simplex viruses using Vaxign reverse vaccinology. BMC Bioinformatics 14 Suppl 4: S2. doi: 10.1186/1471-2105-14-S4-S2 23514126
39. Pascal M, Konstantinou GN, Masilamani M, Lieberman J, Sampson HA, (2013) In silico prediction of Ara h 2 T cell epitopes in peanut-allergic children. Clin Exp Allergy 43: 116–127. doi: 10.1111/cea.12014 23278886
40. Munikumar M, Priyadarshini IV, Pradhan D, Umamaheswari A, Vengamma B, (2013) Computational approaches to identify common subunit vaccine candidates against bacterial meningitis. Interdiscip Sci 5: 155–164. doi: 10.1007/s12539-013-0161-1 23740398
41. Rani R, Marcos C, Lazaro AM, Zhang Y, Stastny P, (2007) Molecular diversity of HLA-A,-B and -C alleles in a North Indian population as determined by PCR-SSOP. Int J Immunogenet 34: 201–208 17504510
42. Fadouloglou VE, Kokkinidis M, Glykos NM, (2008) Determination of protein oligomerization state: two approaches based on glutaraldehyde crosslinking. Anal Biochem 373: 404–406. 18023408
43. North BJ, Verdin E, (2004) Sirtuins: Sir2-related NAD-dependent protein deacetylases. Genome Biol 5: 224. 15128440
44. Ding AH, Nathan CF, Stuehr DJ, (1988) Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 141: 2407–2412. 3139757
45. Samant M, Gupta R, Kumari S, Misra P, Khare P, et al. (2009) Immunization with the DNA-encoding N-terminal domain of proteophosphoglycan of Leishmania donovani generates Th1-type immunoprotective response against experimental visceral leishmaniasis. J Immunol 183: 470–479. doi: 10.4049/jimmunol.0900265 19542458
46. Melby PC, Tryon VV, Chandrasekar B, Freeman GL, (1998) Cloning of Syrian hamster (Mesocricetus auratus) cytokine cDNAs and analysis of cytokine mRNA expression in experimental visceral leishmaniasis. Infect Immun 66: 2135–2142. 9573100
47. Schumacher TN, De Bruijn ML, Vernie LN, Kast WM, Melief CJ, et al. (1991) Peptide selection by MHC class I molecules. Nature 350: 703–706. 1708852
48. Chang ST, Ghosh D, Kirschner DE, Linderman JJ, (2006) Peptide length-based prediction of peptide-MHC class II binding. Bioinformatics 22: 2761–2767. 17000752
49. Kumari S, Samant M, Khare P, Sundar S, Sinha S, et al. (2008) Induction of Th1-type cellular responses in cured/exposed Leishmania-infected patients and hamsters against polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa. Vaccine 26: 4813–4818. doi: 10.1016/j.vaccine.2008.06.102 18656517
50. Klar AJ, Fogel S, Macleod K, (1979) MAR1-a Regulator of the HMa and HMalpha Loci in saccharomyces cerevisiae. Genetics 93: 37–50. 17248968
51. Bell SD, Botting CH, Wardleworth BN, Jackson SP, White MF, (2002) The interaction of Alba, a conserved archaeal chromatin protein, with Sir2 and its regulation by acetylation. Science 296: 148–151. 11935028
52. Starai VJ, Celic I, Cole RN, Boeke JD, Escalante-Semerena JC, (2002) Sir2-dependent activation of acetyl-CoA synthetase by deacetylation of active lysine. Science 298: 2390–2392. 12493915
53. Astrom SU, Cline TW, Rine J, (2003) The Drosophila melanogaster sir2+ gene is nonessential and has only minor effects on position-effect variegation. Genetics 163: 931–937. 12663533
54. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, et al. (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425: 191–196. 12939617
55. Kaeberlein M, McVey M, Guarente L, (1999) The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev 13: 2570–2580. 10521401
56. Rogina B, Helfand SL, (2004) Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc Natl Acad Sci U S A 101: 15998–16003. 15520384
57. Tissenbaum HA, Guarente L, (2001) Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 410: 227–230. 11242085
58. Luthi-Carter R, Taylor DM, Pallos J, Lambert E, Amore A, et al.(2010) SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis. Proc Natl Acad Sci U S A 107: 7927–7932. doi: 10.1073/pnas.1002924107 20378838
59. Ouaissi M, Ouaissi A, (2006) Histone deacetylase enzymes as potential drug targets in cancer and parasitic diseases. J Biomed Biotechnol 2006: 13474. 16883049
60. Silvestre R, Cordeiro-da-Silva A, Tavares J, Sereno D, Ouaissi A, (2006) Leishmania cytosolic silent information regulatory protein 2 deacetylase induces murine B-cell differentiation and in vivo production of specific antibodies. Immunology 119: 529–540. 17026719
61. Pirmez C, Yamamura M, Uyemura K, Paes-Oliveira M, Conceicao-Silva F, et al. (1993) Cytokine patterns in the pathogenesis of human Leishmaniasis. J Clin Invest 91: 1390–1395. 8473490
62. Liew FY, Li Y, Moss D, Parkinson C, Rogers MV, et al. (1991) Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages. Eur J Immunol 21: 3009–3014. 1721024
63. Holaday BJ, Sadick MD, Wang ZE, Reiner SL, Heinzel FP, et al. (1991) Reconstitution of Leishmania immunity in severe combined immunodeficient mice using Th1- and Th2-like cell lines. J Immunol 147: 1653–1658. 1831830
64. MacMicking J, Xie QW, Nathan C, (1997) Nitric oxide and macrophage function. Annu Rev Immunol 15: 323–350. 9143691
65. Burns JM, Jr.Scott JM, Carvalho EM, Russo DM, March CJ, et al. (1991) Characterization of a membrane antigen of Leishmania amazonensis that stimulates human immune responses. J Immunol 146: 742–748. 1824776
66. Russo DM, Burns JM, Jr.Carvalho EM, Armitage RJ, Grabstein KH, et al. (1991) Human T cell responses to gp63, a surface antigen of Leishmania. J Immunol 147: 3575–3580. 1940356
67. White AC, Jr.Castes M, Garcia L, Trujillo D, Zambrano L, (1992) Leishmania chagasi antigens recognized in cured visceral leishmaniasis and asymptomatic infection. Am J Trop Med Hyg 46: 123–131. 1539745
68. Bosque F, Saravia NG, Valderrama L, Milon G, (2000) Distinct innate and acquired immune responses to Leishmania in putative susceptible and resistant human populations endemically exposed to L. (Viannia) panamensis infection. Scand J Immunol 51: 533–541. 10792848
69. Rodrigues Junior V, Da Silva JS, Campos-Neto A, (1992) Selective inability of spleen antigen presenting cells from Leishmania donovani infected hamsters to mediate specific T cell proliferation to parasite antigens. Parasite Immunol 14: 49–58. 1557230
70. Basu R, Bhaumik S, Basu JM, Naskar K, De T, et al. (2005) Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis. J Immunol 174: 7160–7171. 15905560